BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28242417)

  • 1. Solvent removal precipitation based in situ forming implant for controlled drug delivery in periodontitis.
    Juvekar S; Kathpalia H
    J Control Release; 2017 Apr; 251():75-81. PubMed ID: 28242417
    [No Abstract]   [Full Text] [Related]  

  • 2. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
    Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
    Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent exchange-induced in situ forming gel comprising ethyl cellulose-antimicrobial drugs.
    Phaechamud T; Mahadlek J
    Int J Pharm; 2015 Oct; 494(1):381-92. PubMed ID: 26302862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Antimicrobial Agent Loaded Eudragit RS Solvent Exchange-Induced In Situ Forming Gels for Periodontitis Treatment.
    Phaechamud T; Jantadee T; Mahadlek J; Charoensuksai P; Pichayakorn W
    AAPS PharmSciTech; 2017 Feb; 18(2):494-508. PubMed ID: 27116203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing Solvent Exchange-Induced In Situ Forming Gel from Aqueous Insoluble Polymers as Matrix Base for Periodontitis Treatment.
    Srichan T; Phaechamud T
    AAPS PharmSciTech; 2017 Jan; 18(1):194-201. PubMed ID: 26951505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored Doxycycline Hyclate Loaded In Situ Gel for the Treatment of Periodontitis: Optimization, In Vitro Characterization, and Antimicrobial Studies.
    Ranch KM; Maulvi FA; Koli AR; Desai DT; Parikh RK; Shah DO
    AAPS PharmSciTech; 2021 Feb; 22(3):77. PubMed ID: 33595740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of controlled release dental implants of povidone iodine for periodontitis.
    David AT; Kurien S; Udupa N; Verma BR
    Indian J Dent Res; 1994; 5(3):101-4. PubMed ID: 9495106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparticulate based thermosensitive intra-pocket forming implants for better treatment of bacterial infections in periodontitis.
    Yadav SK; Khan G; Bansal M; Thokala S; Bonde GV; Upadhyay M; Mishra B
    Int J Biol Macromol; 2018 Sep; 116():394-408. PubMed ID: 29746970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrudates of lipophilic tetracycline complexes: A new option for periodontitis therapy.
    Kirchberg M; Eick S; Buchholz M; Kiesow A; Sarembe S; Mäder K
    Int J Pharm; 2019 Dec; 572():118794. PubMed ID: 31678388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.
    Greenstein G; Tonetti M
    J Periodontol; 2000 Jan; 71(1):125-40. PubMed ID: 10695948
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of secnidazole or doxycycline dento-oral gels.
    Gad HA; el-Nabarawi MA; Abd el-Hady SS
    Drug Dev Ind Pharm; 2008 Dec; 34(12):1356-67. PubMed ID: 18785044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
    Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
    Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: role of controlled drug delivery for periodontitis (position paper). The American Academy of Periodontology (2000;71:12-40).
    Finkelman RD
    J Periodontol; 2000 Dec; 71(12):1929-33. PubMed ID: 11156051
    [No Abstract]   [Full Text] [Related]  

  • 16. Local delivery system of doxycycline hyclate based on ε-caprolactone copolymers for periodontitis treatment.
    Kopytynska-Kasperczyk A; Dobrzynski P; Pastusiak M; Jarzabek B; Prochwicz W
    Int J Pharm; 2015 Aug; 491(1-2):335-44. PubMed ID: 26143233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced drug delivery approaches against periodontitis.
    Joshi D; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):363-77. PubMed ID: 25005586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Non-surgical treatment of patients with periodontitis.
    Greenstein G; Ciancio S
    J Periodontol; 1997 Oct; 68(10):1023-8. PubMed ID: 9358372
    [No Abstract]   [Full Text] [Related]  

  • 19. Spherical molecularly imprinted polymers (SMIPs) via a novel precipitation polymerization in the controlled delivery of sulfasalazine.
    Puoci F; Iemma F; Muzzalupo R; Spizzirri UG; Trombino S; Cassano R; Picci N
    Macromol Biosci; 2004 Jan; 4(1):22-6. PubMed ID: 15468283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.
    Tian Y; Shen Y; Jv M
    Drug Deliv; 2016 Oct; 23(8):2726-2735. PubMed ID: 26289210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.